Back to Agenda
Session 7: Public Accountability Around Disclosure and Where Are We Heading?
Session Chair(s)
Merete Joergensen, MBA, MSc
Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark
New initiatives on how to improve, enforce and measure Data Sharing activities are being implemented and published. How are these measured? What has the impact been? How have organisations worked with these new initiatives? Future transparency ambitions, and how can we even get more out of these new initiatives?
Speaker(s)
Trish Groves
Trish Groves
British Medical Journal, United Kingdom
Deputy Editor
Making Publications, Disclosure and Data Sharing Commitments Go Hand in Hand
Lise Baltzer
Novo Nordisk, Denmark
Director for Global Publications
Data sharing the new initiative under the Good Pharma Score Card
Jennifer Miller, PhD
Yale School of Medicine, United States
Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics
FDAAA TrialsTracker and the COMPare Trials project
Ben Goldacre
University of Oxford, United Kingdom
Senior Clinical Research Fellow, CEBM, Department of Primary Care Health Science
Have an account?